Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHAPE and SWE for Diagnosing Chronic Exertional Compartment Syndrome
NCT05247541Phase 3Completed
- Sponsor
- Thomas Jefferson University
- Start
- Jul 2020
- Primary completion
- Mar 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of perflutren lipid microspheres in Chronic Exertional Compartment Syndrome (CECS), sponsored by Thomas Jefferson University. Started Jul 2020; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
Chronic Exertional Compartment Syndrome (CECS)
Beyond the preview
Go deeper on NCT05247541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05247541.